Correction: Evaluation of endoscopic submucosal dissection as a treatment option for duodenal tumors ≥ 20 mm: a systematic review and meta-analysis by lesion size - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Assessment of Endoscopic Submucosal Dissection for Treating Duodenal Tumors ≥ 20 mm: A Systematic Review and Meta-Analysis Based on Lesion Size

  • By

  • Daisuke Minezaki

  • Yusaku Takatori

  • Motohiko Kato

  • Yasunori Sato

  • Kohei Takizawa

  • Koichi Kurahara

  • Naomi Kakushima

  • Nobutsugu Abe

  • Osamu Dohi

  • Satoru Nonaka

  • Seiichiro Fukuhara

  • Shoichi Yoshimizu

  • Shu Hoteya

  • Yasushi Yamasaki

  • Naohisa Yahagi

  • September 30, 2026

Share

Objective:

To correct specific errors in the previously published article regarding the assessment of endoscopic submucosal dissection for duodenal tumors.

Approach:
  • Correction of Enrollment Period: The enrollment period for Inoue et al. (2014) was corrected from 2004–2019 to 1993–2011.
  • Figure Correction: Figure 1 was published incorrectly and has been corrected in the original publication.
  • Supplementary Files Update: Supplementary files 1, 2, 3, 4, and 8 have been replaced with correct versions.
Key Findings:
  • The enrollment period for Inoue et al. (2014) was corrected from 2004–2019 to 1993–2011.
  • Figure 1 was published incorrectly and has been corrected in the original publication.
  • Supplementary files 1, 2, 3, 4, and 8 have been replaced with correct versions.
Conclusion:

The article has been updated to reflect the corrections regarding the enrollment period, figure accuracy, and supplementary files.

Sources:

Original Source(s)

Correction: Evaluation of endoscopic submucosal dissection as a treatment option for duodenal tumors ≥ 20 mm: a systematic review and meta-analysis by lesion size

  • by Daisuke Minezaki, Yusaku Takatori, Motohiko Kato, Yasunori Sato, Kohei Takizawa, Koichi Kurahara, Naomi Kakushima, Nobutsugu Abe, Osamu Dohi, Satoru Nonaka, Seiichiro Fukuhara, Shoichi Yoshimizu, Shu Hoteya, Yasushi Yamasaki, Naohisa Yahagi

  • September 30, 2026

Related Content

When Patients Have No Ride Home: Addressing Transportation Barriers That Exacerbate Disparities in Access to Timely Diagnostic Colonoscopies

Prior vedolizumab exposure and fibroblast-derived MMP13 are associated with ustekinumab nonresponse in ulcerative colitis

Patient outcomes and healthcare utilisation following implementation of an advanced therapy care pathway for inflammatory bowel disease: a multicentre, prospective quasi-experimental preimplementation/postimplementation study in the Netherlands